Dermatology · Mobile, AL
NPI
1538330238
Since 2008
Specialty
Dermatology
Code 207N00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
70 Midtown Park E
Mobile, AL, 36606
Phone (251) 289-1786
Groups this clinician bills Medicare through
Medicare paid, 2024
$221K
4,270 services
Medicare patients, 2024
788
Average age 74
Drug cost, 2024
$891K
2,511 prescriptions
Company payments, 2025
$55K
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ryan B Ramagosa was code 17003 (destruction skin lesion), 1,601 times for 352 patients. In total Ryan B Ramagosa billed 4,270 services in 56 codes, and Medicare paid $221K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,601 | 352 | $4.77 | $7,636 |
| 17000 Destruction Skin Lesion | Office | 485 | 447 | $31.69 | $15K |
| 99213 Office E&M - Established | Office | 414 | 384 | $61.76 | $26K |
| 99214 Office E&M - Established | Office | 340 | 287 | $91.51 | $31K |
| 11102 Skin Biopsy | Office | 328 | 304 | $55.36 | $18K |
| 17110 Destruction Skin Lesion | Office | 291 | 272 | $75.25 | $22K |
| 11103 Skin Biopsy | Office | 94 | 77 | $33.50 | $3,149 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 92 | 21 | $0.70 | $63.96 |
| 12032 Wound Repair - All Levels | Office | 79 | 78 | $204.15 | $16K |
| 17004 Destruction Skin Lesion | Office | 74 | 69 | $115.02 | $8,512 |
| 99204 Office E&M - New | Office | 46 | 46 | $106.58 | $4,903 |
| 17263 Destruction Skin Lesion | Office | 41 | 39 | $129.60 | $5,314 |
| 99203 Office E&M - New | Office | 40 | 40 | $74.89 | $2,996 |
| 11603 Skin Lesion Excision | Office | 39 | 38 | $105.34 | $4,108 |
| 17262 Destruction Skin Lesion | Office | 31 | 30 | $111.11 | $3,445 |
By year: 2022 $235K for 5,775 services; 2023 $372K for 6,132 services; 2024 $221K for 4,270 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 15 | 13 | $8.54 | $128 |
Medicare prescription drug claims, 2024
In 2024, the drug Ryan B Ramagosa prescribed most often to Medicare patients was Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc), with 233 prescriptions and refills. In total Ryan B Ramagosa wrote 2,511 Medicare prescriptions that cost $891K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 233 | 237 | 157 | $4,262 |
| Minoxidil Generic | 173 | 241 | 47 | $2,681 |
| Ammonium Lactate Generic | 159 | 185 | 115 | $4,215 |
| Minocycline Hcl Generic | 150 | 166 | 55 | $3,644 |
| Clobetasol Propionate Generic | 148 | 166 | 84 | $9,267 |
| Finasteride Generic | 146 | 234 | 46 | $1,318 |
| Fluconazole Generic | 125 | 225 | 62 | $1,228 |
| Fluocinolone Acetonide Generic | 121 | 126 | 93 | $8,754 |
| Levocetirizine Dihydrochloride Generic | 121 | 148 | 42 | $1,068 |
| Fluocinonide Generic | 121 | 124 | 81 | $6,213 |
| Triamcinolone Acetonide Generic | 90 | 92 | 57 | $1,575 |
| Clindamycin Phosphate Generic | 75 | 76 | 40 | $3,624 |
| Fluorouracil Generic | 67 | 69 | 60 | $5,915 |
| Alclometasone Dipropionate Generic | 64 | 65 | 47 | $2,529 |
| Ciclopirox Ciclopirox Olamine | 46 | 51 | 26 | $1,131 |
Brand drugs: - claims; generic drugs: 2,326 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ryan B Ramagosa $55K ($55K in general payments such as food, travel and fees) from 18 companies. The largest payer was Galderma Laboratories, L.P. with $46K.
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. GALD.SW | 39 | $46K |
| LEO Pharma Inc. | 24 | $6,272 |
| UCB, Inc. UCB.BR | 8 | $1,435 |
| Janssen Biotech, Inc. JNJ | 7 | $293 |
| Abbvie Inc. ABBV | 10 | $190 |
| Organogenesis Inc. ORGO | 3 | $97.42 |
| Genzyme Corporation SNY | 4 | $76.48 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $74.57 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $54.4 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 3 | $54.17 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.